Metabolomics Reveals Cause of Weaker Bones in Diabetics

News   Jul 10, 2017 | Original Story from New York University

 
Metabolomic Analysis Reveals Underlying Cause of Weaker Bones in Diabetic Mice

Bone marrow scan comparison. The researchers report that hyperglycemic mice (or mice with type 2 diabetes) have a 24-fold higher accumulation of succinate, an intermediate metabolite, in the metabolic pathways of their bone marrow stromal cells. Credit: Li Lab, NYU

 
 
 

RELATED ARTICLES

Prostate- and Colon Cancer Targeted With Tapeworm Drug

News

Recently researchers found that a substance in medicine against parasites like Giardia and Tapeworms, acts like tailored medicine against prostate- and colon cancer.

READ MORE

Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's Disease

News

Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.

READ MORE

New Player in Alzheimer's Disease Pathogenesis Identified

News

Using proteomics, microscopic analysis, and functional assays, scientists have shown that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE